Lv31
276 积分 2023-04-07 加入
Efficacy, drug survival, safety and metabolic parameters of ixekizumab in patients with moderate-to-severe psoriasis in China: A two-year real-world study
2小时前
已完结
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
27天前
已完结
Phenotypic differences in clinical manifestations of generalized pustular psoriasis and severe plaque psoriasis in tropical Taiwan
29天前
已完结
Neurologic Symptoms After177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
2个月前
已完结
Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer
2个月前
已完结
Elements of cancer immunity and the cancer–immune set point
3个月前
已完结
Embracing cancer complexity: Hallmarks of systemic disease
3个月前
已完结
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
3个月前
已完结
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
3个月前
已完结
Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis
3个月前
已完结
皖公网安备34019202002308
